Primary Gross Tumor Volume is an Important Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Trimodality Therapy.

Boggs, Drexell Hunter; Hanna, Andrew; Burrows, Whitney; Horiba, Naomi; Suntharalingam, Mohan

Boggs, Drexell Hunter; Hanna, Andrew; Burrows, Whitney; Horiba, Naomi; Suntharalingam, Mohan.

Affiliation

Boggs DH; University of Maryland Medical Center, Baltimore, MD, USA, dboggs@umm.edu.

J Gastrointest Cancer ; 46(2): 131-7, 2015 Jun.

Article in En | MEDLINE | ID: mdl-25759174

Subject(s)

Adenocarcinoma/pathology; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Squamous Cell/pathology; Esophageal Neoplasms/pathology; Esophagectomy/mortality; Radiotherapy, Conformal/mortality; Adenocarcinoma/mortality; Adenocarcinoma/therapy; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell/mortality; Carcinoma, Squamous Cell/therapy; Combined Modality Therapy; Esophageal Neoplasms/mortality; Esophageal Neoplasms/therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Tumor Burden

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Esophagectomy / Radiotherapy, Conformal Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Gastrointest Cancer Year: 2015 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google